Effectiveness of BNT162b2 and CoronaVac vaccinations against mortality and severe complications after SARS-CoV-2 Omicron BA.2 infection: a case–control study
Data regarding protection against mortality and severe complications after Omicron BA.2 infection with CoronaVac and BNT162b2 vaccines remains limited. We conducted a case–control study to evaluate the risk of severe complications and mortality following 1–3 doses of CoronaVac and BNT162b2 using ele...
Salvato in:
| Autori principali: | , , , , , , , , , , , , , , , , , , , |
|---|---|
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Taylor & Francis Group
2022-12-01
|
| Serie: | Emerging Microbes and Infections |
| Soggetti: | |
| Accesso online: | https://www.tandfonline.com/doi/10.1080/22221751.2022.2114854 |
| Tags: |
Nessun Tag, puoi essere il primo ad aggiungerne!!
|
